Sign In
Buy EMBC
$3.32
-0.170 (-4.87%)
At Close: Jun 03, 2026
embecta to Participate in Investor Events
05:00pm, Monday, 01'st Jun 2026
PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical
EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.
07:00pm, Friday, 29'th May 2026
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors conc
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Embecta (EMBC) To Contact Him Directly To Discuss Their Options
EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.
08:00pm, Wednesday, 27'th May 2026
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors conc
Levi & Korsinsky Investigating Whether Embecta Corp. (EMBC) Misled Investors - Securities Law Violations Possible
08:20pm, Thursday, 21'st May 2026
New York, New York--(Newsfile Corp. - May 21, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Embecta Corp. ("Embecta Corp.") (NASDAQ: EMBC) concerning potentia
EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
08:00pm, Thursday, 21'st May 2026
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning
Embecta Corp. (EMBC) Securities Fraud Investigation - Levi & Korsinsky
09:00am, Wednesday, 20'th May 2026
Embecta's Q2 FY2026 revenue and EPS fell short of both company guidance and Wall Street consensus -- shares dropped more than 25% in a single session. NEW YORK, May 20, 2026 /PRNewswire/ -- Investors
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification
12:06pm, Saturday, 16'th May 2026
Embecta NASDAQ: EMBC President and CEO Devdatt Kurdikar said the company's recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-relate
embecta Completes Acquisition of Owen Mumford Holdings Limited
09:00am, Friday, 15'th May 2026
PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously annou
Levi & Korsinsky Announces Investigation of Securities Claims Against Embecta Corp. (EMBC)
09:00am, Thursday, 14'th May 2026
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (NASDAQ: EMBC) stock dropped more than 25% after the company reported Q2 FY2026 earnings release, which reported results below analyst expectat
Embecta Corp. (EMBC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
08:10pm, Wednesday, 13'th May 2026
Embecta Corp. (EMBC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
EMBC Investor Alert: Levi & Korsinsky Investigates Embecta Corp. (EMBC) for Potential Securities Fraud
09:00am, Wednesday, 13'th May 2026
Embecta guided investors toward a $1.071-$1.093 billion revenue outlook for FY2026 while internal indicators reportedly already signaled the need for a cut -- shares later fell more than 25%. NEW YORK
embecta to Participate at the 2026 BofA Securities Global Health Care Conference
09:00am, Friday, 08'th May 2026
PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las
EMBC ACTIVE INVESTIGATION: Lost Money on Embecta Corp.? Contact Levi & Korsinsky Now
12:40pm, Thursday, 07'th May 2026
New York, New York--(Newsfile Corp. - May 7, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Embecta Corp. ("Embecta Corp.") (NASDAQ: EMBC) concerning potential
Embecta: A Sharp Decline On Q2 Earnings, But There's Still No Opportunity
08:30am, Thursday, 07'th May 2026
Embecta faces accelerating revenue declines, with Q2 2026 sales down 14% and U.S. revenues plunging 29%. EMBC's high debt load could become unsustainable if the revenue declines continue. The company
